Lumbar to Sacral Ventral Nerve Re-Routing

Sponsor
Kenneth Peters, MD (Other)
Overall Status
Completed
CT.gov ID
NCT00378664
Collaborator
William Beaumont Hospitals (Other)
13
1
100

Study Details

Study Description

Brief Summary

To assess the level of improvement in voiding function after lumbar to sacral ventral nerve re-routing procedure in Spinal Cord Injury and spina bifida patients

Condition or Disease Intervention/Treatment Phase
  • Procedure: lumbar to sacral ventral nerve re-routing procedure
Phase 2

Detailed Description

Spinal cord injury (SCI) and spina bifida is a source of irreversible injury to the spinal cord often resulting in paralysis and loss of sensation below the waist. The inability to urinate normally is a consequence of both conditions (neurogenic voiding dysfunction). In spina bifida and spinal cord injury, the nerve that controls the bladder and sphincter (the muscle that squeezes the bladder neck to prevent leaking) may no longer work properly resulting in patients who cannot urinate or are constantly wet.

Most patients will maintain high pressures in their bladder and these elevated pressures will eventually take its toll by causing recurrent urinary tract infections, backup of urine to the kidneys, and marked dilatation of possible further damage to the kidneys. Many patients eventually suffer from irreversible renal (kidney) damage, where dialysis or kidney transplant is the only way to sustain life.

Spinal bifida (present at birth) and SCI (occurs most often early in the fourth decade of life) predominately affect young individuals and longevity and quality of life may be greatly reduced by the presence of bladder, bowel, and sexual dysfunction. In the recent past, medications and catheters were the only way to help cord injured patients empty their bladders. Although clean intermittent catheterization (CIC) provides good maintenance results, medications can help conserve low bladder pressures, and antibiotics sustain an infection free urinary tract, these are difficult bladder management programs to uphold. They are expensive, time consuming, and outcomes are inconsistent.

A new surgical procedure has potential for treatment of spinal cord injuries/ spinal bifida. Recently, Dr. Chuan-Guo Xiao from China developed a surgical procedure of rewiring the nerves in the spinal cord to gain better control of urination and avoid complications of neurogenic bladder. The procedure reconnects live wires (nerves) to dead wires.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Lumbar to Sacral Ventral Nerve Re-Routing
Study Start Date :
Sep 1, 2006
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

All enrollees are included in the intervention - lumbar to sacral ventral nerve re-routing procedure surgical nerve re-routing procedure.

Procedure: lumbar to sacral ventral nerve re-routing procedure
surgical nerve re-routing procedure

Outcome Measures

Primary Outcome Measures

  1. Assess the level of improvement in voiding function after lumbar to sacral ventral nerve re-routing procedure in SCI and spina bifida patients. [evaluated at 6 months and 1 year]

Secondary Outcome Measures

  1. Assess the effect of lumbar to sacral ventral the nerve re-routing on bowel function in SCI and spina bifida patients [evaluated at 6 month and 1 year visit]

  2. Assess the effect of the lumbar to sacral ventral nerve re-routing on health related quality of life in SCI and spina bifida patients [evaluate at 6 month and 1 year]

  3. Assess the effect of the lumbar to sacral ventral nerve re-routing on ability to perform activities of daily living in SCI and spina bifida patients [evaluate at 6 month and 1 year visit]

  4. Assess the effect of the lumbar to sacral ventral nerve re-routing on sexual function in SCI patients 18 years of age and older [evaluate at 6 months and 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Male and female paraplegics 18 years and older with spinal cord lesion above L1 on a CIC program for bladder management and a score of "A" on ASIA scale.

  2. Male and female patients age 6 and older with myelomeningocele spina bifida (surgically closed at birth) on a CIC program for bladder management.

  3. Neurogenic bladder documented by urodynamic testing.

  4. Stable neurogenic bladder dysfunction of at least 1 year or more.

  5. Compliant bladder wall.

  6. Normal renal function.

Exclusion Criteria:
  1. History of bladder cancer, augmentation, or radiation.

  2. Bladder capacity less than 100 milliliters (ml).

  3. Anatomic outlet obstruction or urethral strictures.

  4. Vesico-ureteric reflux grade 2 or higher.

  5. Presence of an ileal conduit or supra-pubic catheter drainage.

  6. Contraindications to general anesthesia or surgery.

  7. Inability to complete follow up visits for 3 years.

  8. Inability to comprehend and answer self-administered questionnaires.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Kenneth Peters, MD
  • William Beaumont Hospitals

Investigators

  • Principal Investigator: Kenneth M Peters, M.D., William Beaumont Hospitals

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00378664
Other Study ID Numbers:
  • 2006-124
First Posted:
Sep 21, 2006
Last Update Posted:
Oct 14, 2015
Last Verified:
Oct 1, 2015
Keywords provided by Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2015